|
TES expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.299320E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.165800E-04 |
| Normal-vs-Stage2 |
1.865730E-02 |
| Normal-vs-Stage3 |
4.687900E-02 |
| Normal-vs-Stage4 |
2.780400E-02 |
| Stage1-vs-Stage2 |
9.668600E-01 |
| Stage1-vs-Stage3 |
6.874400E-02 |
| Stage1-vs-Stage4 |
1.760390E-01 |
| Stage2-vs-Stage3 |
3.009200E-01 |
| Stage2-vs-Stage4 |
4.446400E-01 |
| Stage3-vs-Stage4 |
7.079400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.136170E-03 |
| Normal-vs-AfricanAmerican |
8.434200E-02 |
| Normal-vs-Asian |
1.496780E-01 |
| Caucasian-vs-AfricanAmerican |
5.815600E-01 |
| Caucasian-vs-Asian |
2.955000E-01 |
| AfricanAmerican-vs-Asian |
2.665400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.587400E-04 |
| Normal-vs-Female |
4.228000E-02 |
| Male-vs-Female |
9.496000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.974000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.592300E-04 |
| Normal-vs-Age(61-80Yrs) |
6.103000E-03 |
| Normal-vs-Age(81-100Yrs) |
5.539000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.742200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.320400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.000970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.761200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.453220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.902200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.137610E-01 |
| Normal-vs-Grade 2 |
4.435500E-04 |
| Normal-vs-Grade 3 |
1.647890E-02 |
| Normal-vs-Grade 4 |
5.258000E-02 |
| Grade 1-vs-Grade 2 |
9.537200E-01 |
| Grade 1-vs-Grade 3 |
6.056600E-01 |
| Grade 1-vs-Grade 4 |
6.174600E-01 |
| Grade 2-vs-Grade 3 |
2.890200E-02 |
| Grade 2-vs-Grade 4 |
1.368830E-01 |
| Grade 3-vs-Grade 4 |
9.867400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.956800E-03 |
| Normal-vs-ccB subtype |
5.427500E-04 |
| ccA subtype-vs-ccB subtype |
1.083570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.657300E-03 |
| Normal-vs-N1 |
1.650180E-01 |
| N0-vs-N1 |
9.745200E-01 |
|
|
